Pitts: BIO’s Call for Drastic Regulatory Change Is On Point

Pitts: BIO’s Call for Drastic Regulatory Change

Is On Point

June 27, 2011 — In a recent blog entry on DrugWonks.com, Peter Pitts commended BIO’s proposals to revamp the U.S. regulatory system for new treatments and therapies. Pitts mentions that BIO’s plans, as reported in BioCentury, include a progressive approval pathway for unmet condition therapies, a fixed term for the Commissioner of Food and Drugs, a redefinition of FDA’s mission and the FDA as an independent agency, separate from the Department of Health & Human Services.

I’m very happy with the service and the quality and i recommend your website to my friends whenever i get the chance. Buy clomid online without prescription? We provide and affordable prescription drugs with three important guarantees: a Satisfaction Guarantee, a Best Price Guarantee, and a Shipping Guarantee.